Highlights
A collection of news and information related to Avandia (drug) published by this site and its partners.
Displaying items 1-12 of 20
» View wsbtradio.com items only
1
2
Next >
-
REUTERS SUMMIT-Drugmakers split as demands for open data mount
Reuters(For other news from Reuters Health Summit, click on http://www.reuters.com/summit/Health13) * Growing demands for transparency of clinical trial data * Wider disclosure by EU regulator angers drugmakers * GlaxoSmithKline sets up online system for data...Tags: Merck & Company Incorporated, Science and Technology, Science, S, Lobbying
-
Girardi | Keese
Given its deep bench of skilled trial attorneys—who include partner Amy Fisch Solomon —Girardi | Keese has pioneered litigation in the personal injury field, achieving more than $10 billion for its injured clients. “Amy is truly one of...
Tags: Yasmin (drug), Laws, Litigation, Yaz (drug), Vioxx (drug)
-
State AG sues maker of diabetes drugs for false advertising
Maryland Attorney General Douglas F. Gansler said Wednesday he has filed a lawsuit against GlaxoSmithKline, LLC for falsely saying three of its diabetes drugs were better than others on the market. The company also withheld data that showed the drugs...
Tags: Litigation, Crime, Law and Justice, Justice System, Pharmaceuticals, Diabetes
-
Perfect Pitch
"I want our client to have many more moments like that, tossing his son a baseball. Those are the moments we can't give back to our clients. But what we can do is fight so they have the resources that provide them dignity, a better life and justice."...
Tags: Merck & Company Incorporated, Environmental Issues, Health, San Francisco Giants, Los Angeles Dodgers
-
In a Class by Themselves
"It's critical that consumers be allowed to band together to take on rich, powerful corporations." —Graham LippSmith Girardi Keese has made an art form of the technique, using class and mass actions to help individuals whose homes were not built to...
Tags: Merck & Company Incorporated, Yaz (drug), Economy, Business and Finance, Vioxx (drug), Companies and Corporations
-
What drugs are going generic this year and next
Dozens of brand-name prescription drugs are losing their patent protection, allowing generic versions to enter the market and consumers to save 30 to 80 percent on those medications, said David Belian, director of media relations for the Generic...
Tags: Modafinil, Sjogren's Syndrome, Depression, Avapro (drug), Gaucher's Disease
-
Pennsylvania to receive more than $13 million as part of GlaxoSmithKline healthcare fraud settlement
Assistant Press SecretaryAttorney General Linda Kelly today announced that Pennsylvania will receive more than $13 million as part of the largest healthcare fraud settlement in United States history. Kelly said that GlaxoSmithKline, a British based pharmaceutical company that...Tags: Health, Depression, Paxil (drug), Shingles, Sexual Dysfunction
-
GlaxoSmithKline to pay $3 billion healthcare fraud settlement, U.S. says
Pharmaceutical drug maker GlaxoSmithKline will pay $3 billion and plead guilty to federal charges to resolve a slew of criminal and civil issues stemming from its use of kickbacks, mis-branding and other misconduct to market drugs such as Paxil,...
Tags: U.S. Department of Justice, Paxil (drug), Sexual Dysfunction, Google+, Steve Jobs
-
Taking On the $234-Billion Prescription Drug Industry
With 48 percent of Americans taking at least one prescription drug a month, it’s no surprise that pharmaceutical litigation has become a multi-billion dollar industry. Americans spent $234 billion on medication in 2008 to reduce their cholesterol,...Tags: Merck & Company Incorporated, Science and Technology, Health, Chemical Industry, GlaxoSmithKline PLC
-
Glaxo adds safety restrictions to Avandia label
ReutersWASHINGTON (AP) -- GlaxoSmithKline PLC said Monday it has updated the labeling of its diabetes pill Avandia to include safety restrictions ordered by federal health authorities because of the drug's links to heart attack. The Food and Drug Administration...Tags: U.S. Department of Justice, Heart Problems, Health, IMS Health Incorporated, Elections
-
Sulfonylureas for diabetes increase risk of heart disease and death, study finds
Booster ShotsSulfonylureas, the first family of oral drugs used for treating type 2 diabetes, increase the risk of death from all causes by as much as 61% compared with the newer drug metformin, British researchers have found. Some researchers have suspected......
May 8, 2013
|Story| Reuters
Mar 25, 2013
|Story| Los Angeles Times
Feb 20, 2013
|Story| Baltimore Sun
Jun 13, 2012
|Story| Los Angeles Times
Jun 13, 2012
|Story| Los Angeles Times
Aug 1, 2012
|Story| Chicago Tribune
Jul 2, 2012
|Story| WPMT-LTV
Jul 2, 2012
|Story| Los Angeles Times
Jun 23, 2011
|Story| Los Angeles Times
Feb 7, 2011
|Story| Reuters
Sep 24, 2010
|Resource Link| Health Portal
Dec 4, 2009
| Los Angeles Times
Original site for Avandia (drug) topic gallery.
